miR-106a Is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B and Associated with Enhanced Levels of Interleukin-8
This study aimed to investigate miR-106a expression in peripheral blood mononuclear cells (PBMCs) of chronic hepatitis B (CHB) patients and to analyze the function of miR-106a. miR-106a expression levels in PBMCs from 40 healthy controls and 56 CHB patients were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR). The luciferase activity assays were used to determine whether miR-106a binds to 3'UTR of IL-8. miR-106a mimics and inhibitors were transfected into healthy PBMCs. IL-8 mRNA and protein levels were detected and determined by qRT-PCR and ELISA, respectively. The qRT-PCR results suggested that the PBMC miR-106a levels were decreased in CHB patients. IL-8 was augmented in CHB patients and was inversely correlated with miR-106a levels. The luciferase activity assays indicated that IL-8 is a target of miR-106a. Exogenous expression of miR-106a could significantly repress IL-8 expression at both mRNA and protein levels in PBMCs, whereas miR-106a inhibitor had the opposite effects. This study suggested that miR-106a is downregulated in PBMCs of CHB patients and that miR-106a may play an important role in CHB by targeting IL-8..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2015 |
---|---|
Enthalten in: |
Mediators of inflammation - 2015(2015) |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hong, Zhongsi [VerfasserIn] |
---|
Links: |
Volltext |
---|
doi: |
10.1155/2015/629862 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC1959349503 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1959349503 | ||
003 | DE-627 | ||
005 | 20230714151104.0 | ||
007 | tu | ||
008 | 160206s2015 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1155/2015/629862 |2 doi | |
028 | 5 | 2 | |a PQ20160617 |
035 | |a (DE-627)OLC1959349503 | ||
035 | |a (DE-599)GBVOLC1959349503 | ||
035 | |a (PRQ)d2551-81c572e8956310d61b6dbf20c6ccb47f72cb3f1b8597e94b161bb38931c54213 | ||
035 | |a (KEY)0215234720150000015000000000mir106aisdownregulatedinperipheralbloodmononuclear | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q ZDB |
100 | 1 | |a Hong, Zhongsi |e verfasserin |4 aut | |
245 | 1 | 0 | |a miR-106a Is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B and Associated with Enhanced Levels of Interleukin-8 |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a This study aimed to investigate miR-106a expression in peripheral blood mononuclear cells (PBMCs) of chronic hepatitis B (CHB) patients and to analyze the function of miR-106a. miR-106a expression levels in PBMCs from 40 healthy controls and 56 CHB patients were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR). The luciferase activity assays were used to determine whether miR-106a binds to 3'UTR of IL-8. miR-106a mimics and inhibitors were transfected into healthy PBMCs. IL-8 mRNA and protein levels were detected and determined by qRT-PCR and ELISA, respectively. The qRT-PCR results suggested that the PBMC miR-106a levels were decreased in CHB patients. IL-8 was augmented in CHB patients and was inversely correlated with miR-106a levels. The luciferase activity assays indicated that IL-8 is a target of miR-106a. Exogenous expression of miR-106a could significantly repress IL-8 expression at both mRNA and protein levels in PBMCs, whereas miR-106a inhibitor had the opposite effects. This study suggested that miR-106a is downregulated in PBMCs of CHB patients and that miR-106a may play an important role in CHB by targeting IL-8. | ||
540 | |a Nutzungsrecht: Copyright © 2015 Zhongsi Hong et al. 2015 | ||
650 | 4 | |a Chemokines | |
650 | 4 | |a Liver cancer | |
650 | 4 | |a Viral infections | |
650 | 4 | |a Deoxyribonucleic acid--DNA | |
650 | 4 | |a Studies | |
650 | 4 | |a Epigenetics | |
650 | 4 | |a Medical prognosis | |
650 | 4 | |a Pathogenesis | |
650 | 4 | |a Cytomegalovirus | |
650 | 4 | |a Inflammation | |
650 | 4 | |a Hepatitis | |
650 | 4 | |a Gene expression | |
650 | 4 | |a Health care | |
650 | 4 | |a Infectious diseases | |
650 | 4 | |a DNA methylation | |
650 | 4 | |a Cytokines | |
650 | 4 | |a Proteins | |
650 | 4 | |a Infections | |
650 | 4 | |a Hospitals | |
650 | 4 | |a RB1-214 | |
650 | 4 | |a Pathology | |
650 | 4 | |a Medicine | |
700 | 1 | |a Hong, Haiyu |4 oth | |
700 | 1 | |a Liu, Jian |4 oth | |
700 | 1 | |a Zheng, Xiaobin |4 oth | |
700 | 1 | |a Huang, Mingxing |4 oth | |
700 | 1 | |a Li, Chunna |4 oth | |
700 | 1 | |a Xia, Jinyu |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Mediators of inflammation |d Sylvania, Ohio : Hindawi Publishing Corp., 1992 |g 2015(2015) |w (DE-627)170995852 |w (DE-600)1137605-3 |w (DE-576)9170995850 |x 0962-9351 |7 nnns |
773 | 1 | 8 | |g volume:2015 |g year:2015 |
856 | 4 | 1 | |u http://dx.doi.org/10.1155/2015/629862 |3 Volltext |
856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26265888 |
856 | 4 | 2 | |u http://search.proquest.com/docview/1709456730 |
856 | 4 | 2 | |u http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4525765&tool=pmcentrez&rendertype=abstract |
856 | 4 | 2 | |u https://doaj.org/article/8894a28b6c1e4bdc87dd4590c7fef27e |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_4219 | ||
951 | |a AR | ||
952 | |d 2015 |j 2015 |